Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Thickeners and Stabilizers
Direct Compression
Lubricants & Glidants
Granulation
Disintegrants & Superdisintegrants
Coating Systems & Additives
Solubilizers
Controlled & Modified Release
Co-Processed Excipients
Taste Masking
Film Formers & Plasticizers
Empty Capsules
Rheology Modifiers
Emulsifying Agents
Chewable & Orodispersible Aids
Parenteral
Topical
Coloring Agents
API Stability Enhancers
Surfactant & Foaming Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
98
PharmaCompass offers a list of Rifampin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rifampin manufacturer or Rifampin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rifampin manufacturer or Rifampin supplier.
PharmaCompass also assists you with knowing the Rifampin API Price utilized in the formulation of products. Rifampin API Price is not always fixed or binding as the Rifampin Price is obtained through a variety of data sources. The Rifampin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rimactan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rimactan, including repackagers and relabelers. The FDA regulates Rimactan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rimactan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rimactan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rimactan supplier is an individual or a company that provides Rimactan active pharmaceutical ingredient (API) or Rimactan finished formulations upon request. The Rimactan suppliers may include Rimactan API manufacturers, exporters, distributors and traders.
click here to find a list of Rimactan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rimactan DMF (Drug Master File) is a document detailing the whole manufacturing process of Rimactan active pharmaceutical ingredient (API) in detail. Different forms of Rimactan DMFs exist exist since differing nations have different regulations, such as Rimactan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rimactan DMF submitted to regulatory agencies in the US is known as a USDMF. Rimactan USDMF includes data on Rimactan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rimactan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rimactan suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Rimactan Drug Master File in Japan (Rimactan JDMF) empowers Rimactan API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Rimactan JDMF during the approval evaluation for pharmaceutical products. At the time of Rimactan JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Rimactan suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Rimactan Drug Master File in Korea (Rimactan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Rimactan. The MFDS reviews the Rimactan KDMF as part of the drug registration process and uses the information provided in the Rimactan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Rimactan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Rimactan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Rimactan suppliers with KDMF on PharmaCompass.
A Rimactan CEP of the European Pharmacopoeia monograph is often referred to as a Rimactan Certificate of Suitability (COS). The purpose of a Rimactan CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Rimactan EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Rimactan to their clients by showing that a Rimactan CEP has been issued for it. The manufacturer submits a Rimactan CEP (COS) as part of the market authorization procedure, and it takes on the role of a Rimactan CEP holder for the record. Additionally, the data presented in the Rimactan CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Rimactan DMF.
A Rimactan CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Rimactan CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Rimactan suppliers with CEP (COS) on PharmaCompass.
A Rimactan written confirmation (Rimactan WC) is an official document issued by a regulatory agency to a Rimactan manufacturer, verifying that the manufacturing facility of a Rimactan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Rimactan APIs or Rimactan finished pharmaceutical products to another nation, regulatory agencies frequently require a Rimactan WC (written confirmation) as part of the regulatory process.
click here to find a list of Rimactan suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rimactan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rimactan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rimactan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rimactan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rimactan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rimactan suppliers with NDC on PharmaCompass.
Rimactan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rimactan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rimactan GMP manufacturer or Rimactan GMP API supplier for your needs.
A Rimactan CoA (Certificate of Analysis) is a formal document that attests to Rimactan's compliance with Rimactan specifications and serves as a tool for batch-level quality control.
Rimactan CoA mostly includes findings from lab analyses of a specific batch. For each Rimactan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rimactan may be tested according to a variety of international standards, such as European Pharmacopoeia (Rimactan EP), Rimactan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rimactan USP).
